Mary Jo Turk
- Immunology top 0.5%
- Immunotherapy and Immune Responses 37
- T-cell and B-cell Immunology 28
- Immune Cell Function and Interaction 25
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 28
- CAR-T cell therapy research 17
- Cytokine Signaling Pathways and Interactions 5
- Biomaterials top 2%
- Molecular Biology top 5%
- Melanoma and MAPK Pathways 8
- Biotechnology top 5%
-
- melanin and skin pigmentation 5
- Co-authors
- Philip S. LowChristopher P. LeamonElaine WestrickJeffrey D. LewisNikki ParkerAlan N. HoughtonJosé A. Guevara-PatiñoGabrielle Rizzuto
- Cited by
- ImmunologyOncologyBiomaterials
- Journals
- Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Mary Jo Turk
63 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Immunology 3.0k
- Oncology 2.2k
- Biomaterials 696
- Molecular Biology 1.6k
- Biotechnology 153
Countries citing papers authored by Mary Jo Turk
This map shows the geographic impact of Mary Jo Turk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo Turk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo Turk more than expected).
Fields of papers citing papers by Mary Jo Turk
This network shows the impact of papers produced by Mary Jo Turk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo Turk. The network helps show where Mary Jo Turk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mary Jo Turk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 5 | |
| 3 | 2019 | 51 | |
| 4 | 2018 | 77 | |
| 5 | 2018 | 22 | |
| 6 | 2018 | 90 | |
| 7 | 2018 | 33 | |
| 8 | 2017 | 79 | |
| 9 | 2017 | 201 | |
| 10 | 2017 | 79 | |
| 11 | 2016 | 309 | |
| 12 | 2015 | 34 | |
| 13 | 2014 | 57 | |
| 14 | 2012 | 37 | |
| 15 | 2010 | 1 | |
| 16 | 2007 | 1 | |
| 17 | 2006 | 54 | |
| 18 | 2004 | 433 | |
| 19 | 2003 | 77 | |
| 20 | 2002 | 95 |
About Mary Jo Turk
Mary Jo Turk is a scholar working on Immunology, Oncology and Biomaterials, having authored 67 papers that have together received 5.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (37 papers), Cancer Immunotherapy and Biomarkers (28 papers), T-cell and B-cell Immunology (28 papers), Immune Cell Function and Interaction (25 papers), CAR-T cell therapy research (17 papers), Melanoma and MAPK Pathways (8 papers), melanin and skin pigmentation (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (2.2k citations) and Biomaterials (696 citations). Mary Jo Turk has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Philip S. Low, Christopher P. Leamon, Elaine Westrick, Jeffrey D. Lewis, Nikki Parker, Alan N. Houghton, José A. Guevara-Patiño, Gabrielle Rizzuto, Manuel E. Engelhorn and Katelyn T. Byrne. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.